cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications-Reference-Cited by-同舟云学术

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications

Published:2015-10 Issue:4 Volume:5 Page:647-659
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Baghbaderani Behnam Ahmadian,Tian Xinghui,Neo Boon Hwa,Burkall Amy,Dimezzo Tracy,Sierra Guadalupe,Zeng Xianmin,Warren Kim,Kovarcik Don Paul,Fellner Thomas,Rao Mahendra S.

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference33 articles.

1. Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development;Ancans;Front. Immunol.,2012

2. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells;Andrews;Nat. Biotechnol.,2014

3. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI);Andrews;Regen. Med.,2015

4. Concise review: making and using clinically compliant pluripotent stem cell lines;Carpenter;Stem Cells Transl. Med.,2015

5. Chemically defined conditions for human iPSC derivation and culture;Chen;Nat. Methods,2011

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human induced pluripotent stem cells for live cell cycle monitoring and endogenous gene activation;Stem Cell Research;2024-10

2. Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system;Cytotherapy;2024-09

3. The Development in the Regenerative Medicine Industry: Analysis on Global Technology Trends and Local Academic-industry Cooperation Modes;2024 Portland International Conference on Management of Engineering and Technology (PICMET);2024-08-04

4. Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy;iScience;2024-08

5. GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy;Stem Cells Translational Medicine;2024-07-23